Sensei Biotherapeutics, Inc.
SNSE
$12.63
-$0.37-2.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3,508.99% | -3.26% | 7.46% | 28.09% | 11.66% |
| Total Depreciation and Amortization | -11.76% | 0.00% | -8.11% | 8.82% | -89.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27,320.83% | 11.27% | 0.21% | -19.66% | -57.41% |
| Change in Net Operating Assets | 4,557.34% | -39.02% | 131.52% | -73.22% | -443.60% |
| Cash from Operations | -177.77% | -7.75% | 39.31% | 16.70% | -22.48% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | 425.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,920.95% | 19.39% | -79.64% | 19.75% | 326.94% |
| Cash from Investing | -1,610.62% | 19.39% | -80.10% | 21.78% | 328.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 45.13% | 25.66% | 51.59% | -48.82% | -1.93% |
| Issuance of Common Stock | 51,550.00% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -99.29% | -- | -- |
| Cash from Financing | 167,510.81% | 26.97% | 9.52% | 21.50% | -10.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7,684.85% | 5.06% | -174.44% | 2,390.60% | 98.72% |